Omeprazole in infants with cimetidine-resistant peptic esophagitis

Twelve neurologically normal infants (age 2.9 ± 0.9 months) with peptic esophagitis (grade 2) who did not respond to cimetidine (in addition to positioning, cisapride, and Gaviscon) were treated with omeprazole, 0.5 mg/kg once a day, for 6 weeks. The effectiveness of omeprazole was evaluated in all...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of pediatrics 1998-02, Vol.132 (2), p.352-354
Main Authors: Alliët, Philippe, Raes, Marc, Bruneel, Els, Gillis, Philippe
Format: Article
Language:English
Subjects:
Anti-Ulcer Agents - therapeutic use
Biological and medical sciences
Cimetidine - therapeutic use
Digestive system
Esophagitis, Peptic - drug therapy
Gastroenterology. Liver. Pancreas. Abdomen
Histamine H2 Antagonists - therapeutic use
Humans
Infant
Medical sciences
Omeprazole - therapeutic use
Other diseases. Semiology
Pharmacology. Drug treatments
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Treatment Failure
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c389t-4691eb4aa16066993a0927b58deb2a0fec0d83f0de0c413b8c02f41540830fff3
cites cdi_FETCH-LOGICAL-c389t-4691eb4aa16066993a0927b58deb2a0fec0d83f0de0c413b8c02f41540830fff3
container_end_page 354
container_issue 2
container_start_page 352
container_title The Journal of pediatrics
container_volume 132
creator Alliët, Philippe
Raes, Marc
Bruneel, Els
Gillis, Philippe
description Twelve neurologically normal infants (age 2.9 ± 0.9 months) with peptic esophagitis (grade 2) who did not respond to cimetidine (in addition to positioning, cisapride, and Gaviscon) were treated with omeprazole, 0.5 mg/kg once a day, for 6 weeks. The effectiveness of omeprazole was evaluated in all infants by clinical assessment and endoscopy before and after treatment and by 24-hour gastric pH monitoring during treatment in seven infants. Omeprazole therapy led to a marked decrease in symptoms, endoscopic and histologic signs of esophagitis, and intragastric acidity. (J Pediatr 1998;132:352-4)
doi_str_mv 10.1016/S0022-3476(98)70460-3
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79733520</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022347698704603</els_id><sourcerecordid>79733520</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-4691eb4aa16066993a0927b58deb2a0fec0d83f0de0c413b8c02f41540830fff3</originalsourceid><addsrcrecordid>eNqFkMlKBDEQhoMoOi6PIPRBRA-tlU53OjmJihsIHtRzSKcrGunNJKPo0xudYa5CQR3-rxY-QvYpnFCg_PQRoChyVtb8SIrjGkoOOVsjMwqyzrlgbJ3MVsgW2Q7hDQBkCbBJNmUFnFd8Ri4eepy8_h47zNyQyuohhuzTxdfMuB6ja92AucfgQkxRNuEUnckwjNOrfnHRhV2yYXUXcG_Zd8jz9dXT5W1-_3Bzd3l-nxsmZMxLLik2pdaUp9tSMg2yqJtKtNgUGiwaaAWz0CKYkrJGGChsSasSBANrLdshh4u9kx_f5xii6l0w2HV6wHEeVC1rxqoCElgtQOPHEDxaNXnXa_-lKKhfd-rPnfoVo6RQf-4US3P7ywPzpsd2NbWUlfKDZa6D0Z31ejAurLCCirRVJuxsgWGS8eHQq2AcDgZb59FE1Y7un0d-AM34ix0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79733520</pqid></control><display><type>article</type><title>Omeprazole in infants with cimetidine-resistant peptic esophagitis</title><source>ScienceDirect Freedom Collection</source><creator>Alliët, Philippe ; Raes, Marc ; Bruneel, Els ; Gillis, Philippe</creator><creatorcontrib>Alliët, Philippe ; Raes, Marc ; Bruneel, Els ; Gillis, Philippe</creatorcontrib><description>Twelve neurologically normal infants (age 2.9 ± 0.9 months) with peptic esophagitis (grade 2) who did not respond to cimetidine (in addition to positioning, cisapride, and Gaviscon) were treated with omeprazole, 0.5 mg/kg once a day, for 6 weeks. The effectiveness of omeprazole was evaluated in all infants by clinical assessment and endoscopy before and after treatment and by 24-hour gastric pH monitoring during treatment in seven infants. Omeprazole therapy led to a marked decrease in symptoms, endoscopic and histologic signs of esophagitis, and intragastric acidity. (J Pediatr 1998;132:352-4)</description><identifier>ISSN: 0022-3476</identifier><identifier>EISSN: 1097-6833</identifier><identifier>DOI: 10.1016/S0022-3476(98)70460-3</identifier><identifier>PMID: 9506656</identifier><identifier>CODEN: JOPDAB</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Anti-Ulcer Agents - therapeutic use ; Biological and medical sciences ; Cimetidine - therapeutic use ; Digestive system ; Esophagitis, Peptic - drug therapy ; Gastroenterology. Liver. Pancreas. Abdomen ; Histamine H2 Antagonists - therapeutic use ; Humans ; Infant ; Medical sciences ; Omeprazole - therapeutic use ; Other diseases. Semiology ; Pharmacology. Drug treatments ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Treatment Failure ; Treatment Outcome</subject><ispartof>The Journal of pediatrics, 1998-02, Vol.132 (2), p.352-354</ispartof><rights>1998 Mosby, Inc.</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-4691eb4aa16066993a0927b58deb2a0fec0d83f0de0c413b8c02f41540830fff3</citedby><cites>FETCH-LOGICAL-c389t-4691eb4aa16066993a0927b58deb2a0fec0d83f0de0c413b8c02f41540830fff3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2180229$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9506656$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alliët, Philippe</creatorcontrib><creatorcontrib>Raes, Marc</creatorcontrib><creatorcontrib>Bruneel, Els</creatorcontrib><creatorcontrib>Gillis, Philippe</creatorcontrib><title>Omeprazole in infants with cimetidine-resistant peptic esophagitis</title><title>The Journal of pediatrics</title><addtitle>J Pediatr</addtitle><description>Twelve neurologically normal infants (age 2.9 ± 0.9 months) with peptic esophagitis (grade 2) who did not respond to cimetidine (in addition to positioning, cisapride, and Gaviscon) were treated with omeprazole, 0.5 mg/kg once a day, for 6 weeks. The effectiveness of omeprazole was evaluated in all infants by clinical assessment and endoscopy before and after treatment and by 24-hour gastric pH monitoring during treatment in seven infants. Omeprazole therapy led to a marked decrease in symptoms, endoscopic and histologic signs of esophagitis, and intragastric acidity. (J Pediatr 1998;132:352-4)</description><subject>Anti-Ulcer Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Cimetidine - therapeutic use</subject><subject>Digestive system</subject><subject>Esophagitis, Peptic - drug therapy</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Histamine H2 Antagonists - therapeutic use</subject><subject>Humans</subject><subject>Infant</subject><subject>Medical sciences</subject><subject>Omeprazole - therapeutic use</subject><subject>Other diseases. Semiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Treatment Failure</subject><subject>Treatment Outcome</subject><issn>0022-3476</issn><issn>1097-6833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkMlKBDEQhoMoOi6PIPRBRA-tlU53OjmJihsIHtRzSKcrGunNJKPo0xudYa5CQR3-rxY-QvYpnFCg_PQRoChyVtb8SIrjGkoOOVsjMwqyzrlgbJ3MVsgW2Q7hDQBkCbBJNmUFnFd8Ri4eepy8_h47zNyQyuohhuzTxdfMuB6ja92AucfgQkxRNuEUnckwjNOrfnHRhV2yYXUXcG_Zd8jz9dXT5W1-_3Bzd3l-nxsmZMxLLik2pdaUp9tSMg2yqJtKtNgUGiwaaAWz0CKYkrJGGChsSasSBANrLdshh4u9kx_f5xii6l0w2HV6wHEeVC1rxqoCElgtQOPHEDxaNXnXa_-lKKhfd-rPnfoVo6RQf-4US3P7ywPzpsd2NbWUlfKDZa6D0Z31ejAurLCCirRVJuxsgWGS8eHQq2AcDgZb59FE1Y7un0d-AM34ix0</recordid><startdate>19980201</startdate><enddate>19980201</enddate><creator>Alliët, Philippe</creator><creator>Raes, Marc</creator><creator>Bruneel, Els</creator><creator>Gillis, Philippe</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19980201</creationdate><title>Omeprazole in infants with cimetidine-resistant peptic esophagitis</title><author>Alliët, Philippe ; Raes, Marc ; Bruneel, Els ; Gillis, Philippe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-4691eb4aa16066993a0927b58deb2a0fec0d83f0de0c413b8c02f41540830fff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Anti-Ulcer Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Cimetidine - therapeutic use</topic><topic>Digestive system</topic><topic>Esophagitis, Peptic - drug therapy</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Histamine H2 Antagonists - therapeutic use</topic><topic>Humans</topic><topic>Infant</topic><topic>Medical sciences</topic><topic>Omeprazole - therapeutic use</topic><topic>Other diseases. Semiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Treatment Failure</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alliët, Philippe</creatorcontrib><creatorcontrib>Raes, Marc</creatorcontrib><creatorcontrib>Bruneel, Els</creatorcontrib><creatorcontrib>Gillis, Philippe</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alliët, Philippe</au><au>Raes, Marc</au><au>Bruneel, Els</au><au>Gillis, Philippe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Omeprazole in infants with cimetidine-resistant peptic esophagitis</atitle><jtitle>The Journal of pediatrics</jtitle><addtitle>J Pediatr</addtitle><date>1998-02-01</date><risdate>1998</risdate><volume>132</volume><issue>2</issue><spage>352</spage><epage>354</epage><pages>352-354</pages><issn>0022-3476</issn><eissn>1097-6833</eissn><coden>JOPDAB</coden><abstract>Twelve neurologically normal infants (age 2.9 ± 0.9 months) with peptic esophagitis (grade 2) who did not respond to cimetidine (in addition to positioning, cisapride, and Gaviscon) were treated with omeprazole, 0.5 mg/kg once a day, for 6 weeks. The effectiveness of omeprazole was evaluated in all infants by clinical assessment and endoscopy before and after treatment and by 24-hour gastric pH monitoring during treatment in seven infants. Omeprazole therapy led to a marked decrease in symptoms, endoscopic and histologic signs of esophagitis, and intragastric acidity. (J Pediatr 1998;132:352-4)</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>9506656</pmid><doi>10.1016/S0022-3476(98)70460-3</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3476
ispartof The Journal of pediatrics, 1998-02, Vol.132 (2), p.352-354
issn 0022-3476
1097-6833
language eng
recordid cdi_proquest_miscellaneous_79733520
source ScienceDirect Freedom Collection
subjects Anti-Ulcer Agents - therapeutic use
Biological and medical sciences
Cimetidine - therapeutic use
Digestive system
Esophagitis, Peptic - drug therapy
Gastroenterology. Liver. Pancreas. Abdomen
Histamine H2 Antagonists - therapeutic use
Humans
Infant
Medical sciences
Omeprazole - therapeutic use
Other diseases. Semiology
Pharmacology. Drug treatments
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Treatment Failure
Treatment Outcome
title Omeprazole in infants with cimetidine-resistant peptic esophagitis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T13%3A05%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Omeprazole%20in%20infants%20with%20cimetidine-resistant%20peptic%20esophagitis&rft.jtitle=The%20Journal%20of%20pediatrics&rft.au=Alli%C3%ABt,%20Philippe&rft.date=1998-02-01&rft.volume=132&rft.issue=2&rft.spage=352&rft.epage=354&rft.pages=352-354&rft.issn=0022-3476&rft.eissn=1097-6833&rft.coden=JOPDAB&rft_id=info:doi/10.1016/S0022-3476(98)70460-3&rft_dat=%3Cproquest_cross%3E79733520%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c389t-4691eb4aa16066993a0927b58deb2a0fec0d83f0de0c413b8c02f41540830fff3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=79733520&rft_id=info:pmid/9506656&rfr_iscdi=true